Bibliografia

1. Delmonte A., Sessa C.: Molekularne ukierunkowane leczenie chorych na raka

trzonu macicy. Onkologia po Dyplomie 2. 2009; 6: 75-80.

3. Tavassoli F.A., Devilee P.: World Health Organization Classification of

Tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs. IARC Press, Lyon 2003: 217-257. 4. Deligdisch L.: Early diagnosis of endometrial cancer. W: Deligdisch L. (red.): Early Pathologic Diagnosis of Gynecologic Cancer Including a Clinicians View. World Scientific Publishing Co., 2009: 149-173. 5. Silverberg S.G.: The endometrium. Arch. Pathol. Lab. Med. 2007; 131: 372382.
6. Soslow R.A., Bissonnette J.P., Wilton A. i wsp.: Clinicopathologic analysis of

187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences. Am. J. Surg. Pathol. 2007; 31: 979-987. 7. Zaino R.J.: FIGO staging of endometrial adenocarcinoma: a critical review and proposal. Int. J. Gynecol. Pathol. 2009; 28: 1-9.
8. Alkushi A., Abdul-Rahman Z.H., Lim P. i wsp.: Description of a novel system

for grading of endometrial carcinoma and comparison with existing grading systems. Am. J. Surg. Pathol. 2005; 29: 295-304.
9. Dec G., Romanowicz-Makowska H., Smolarz B., Kulig A.: Analiza markerw

niestabilnoci mikrosatelitarnej u kobiet z rakiem endometrium. Przegld Menopauzalny 2004; 8: 14-18.

10. Sobczuk

A., Smolarz B., Romanowicz-Makowska H., Pertyski T.:

Niestabilno mikrosatelitarna u kobiet z rakiem endometrium z regionu dzkiego. Przegld Menopauzalny 2008; 12: 42-45.
11. Garg K., Leitao M.M. Jr, Kauff N.D. i wsp.: Selection of endometrial

carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.

12.Am. J. Surg. Pathol. 2009; 33: 925-933.

13. Bansal N., Yendluri V., Wenham R.M.: The molecular biology of endometrial

cancers and the implications for pathogenesis, classification, and targeted therapies. Cancer Control 2009; 16: 8-13.
14. Jesionek-Kupnicka D., Biekiewicz A.: Rak trzonu macicy. [w:] Onkologia.

Podrcznik dla studentow i lekarzy. R. Kordek, J. Jassem, M. Krzakowski, A. Jeziorski (red.). Medical Press, Gdask 2004, 160-161.
15. Amant F., Moerman P., Neven P. i wsp.: Endometrial cancer. Lancet, 2005,

366, 491-505.
16. Gottwald L., Akoel K., Wojcik-Krowiranda K. i wsp.: Nowotwory zoliwe

narzdow pciowych u kobiet w okresie senium. Ginekol. Pol., 2003, 74, 9, 714-717.
17. The Seventh Report of the Joint National Committee on Prevention,Detection,

Evaluation and Treatment of High Blood Pressure.The JNC 7 Report. JAMA, 2003, 289, 2560-2575.
18. American Diabetes Association: Treatment of hypertension in adults with

diabetes. Diabetes Care, 2003, 26, supl 1., S80-S82.

19. Bokhman J.V.: Two pathogenic types of endometrial carcinoma. Gynecol.

Oncol., 1993, 9, 330-500.

20. Emons G., Fleckenstein G., Hinney B. i wsp.: Hormonal interactions in

endometrial cancer. Endocr. Relat. Cancer, 2000, 7, 227.

21. Sherman M.E.: Theories of endometrial carcinogenesis: a multidisciplinary

approach. Mod. Pathol., 2000, 13, 295.

22. Bonfi tto V.L., Andrade L.A.: P53, estrogen and progesterone receptors in

diagnostic curettage for endometrial adenocarcinoma and their correlation with morphological data and disease stage at hysterectomy. Sao Paulo Med. J., 2003, 121, 163.
23. Dahmoun M., Backstrom T., Boman K., Cajander S.: Apoptosis, proliferation,

and hormone receptors in endometrial carcinoma: results depending on methods of analysis. Int. J. Oncol., 2003, 22, 115. Furberg A.S., Thune I.: Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high

energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int. J. Cancer, 2003, 104, 669-676.
24. Joska J., Krynicki R., Lindner B. i wsp.: Czy znamy najbardziej korzystny

sposb postpowania we wczesnym stopniu klinicznego zaawansowania raka trzonu macicy? PN. Menopauz., 2003, 3, 54-60.
25. Lukanova A., Lundin E., Micheli A. i wsp.: Circulating levels of sex steroid

hormones and risk of endometrial cancer in postmenopausal women. Int. J. Cancer, 2004, 108, 425.
26. Markowska J. (red.): Rak bony luzowej trzonu macicy. Springer PWN,

Warszawa 1998, 604-720.

27. Bornstein J., Auslender R., Goldstein S. i wsp.: Increased endometrial thickness

in women with hypertension. Am. J. Obstet. Gynecol., 2000, 183, 583-587.

28. Kusiska R.: Epidemiologia nowotworow. [w:] Onkologia. Podrcznik dla

studentow i lekarzy. R. Kordek, J. Jassem, M. Krzakowski, A. Jeziorski (red.). Medical Press, Gdask 2004, 15-18.
29. Wasthoff C., Hellen D., Drosinos S. i wsp.: RSC factors for hyperplasia

associated versus atrophy- associated endometrial carcinoma. Am. J. Obstem. Gynecol., 2003, 182, 506-508.
30. Munstedt K., Grant P., Woenckhaus J. i wsp.: Cancer of the endometrium:

current aspects of diagnostics and treatment. World J. Surg. Oncol., 2004, 2, 24.